Downregulation of the nucleosome-binding protein 1 (NSBP1) gene can inhibit the in vitro and in vivo proliferation of prostate cancer cells

Asian Journal of Andrology

Volumn 12, Issue 5, 2010, Pages 709-717

  Jiang, Ning ^a,b,c   Zhou, Li Qun ^a,b,c   Zhang, Xiao Yu ^a,b,c  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c NATIONAL UROLOGICAL CANCER CENTER   (China)

Author keywords

apoptosis; NSBP1; proliferation; prostate cancer; RNA interference

Indexed keywords

CELL PROTEIN; CYCLIN B1; LENTIVIRUS VECTOR; NUCLEOSOME BINDING PROTEIN 1; PROTEIN BCL 2; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL GROWTH; CELL PROLIFERATION; FLOW CYTOMETRY; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PROSTATE CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN B1; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENETIC VECTORS; HMGN PROTEINS; HUMANS; LENTIVIRUS; MALE; MICE; MICE, INBRED BALB C; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA INTERFERENCE; TRANS-ACTIVATORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77956449984     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2010.39     Document Type: Article

References (31)

1. Jemal A, Sieqel R, Ward E, Hao Y, Xu J, et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49.
2. Yang XZ, Zhou LQ, Zhou J, Wang X, Yang F, et al. Cloning of the prostate cancer related genes with mRNA differential display. Chin J Urol 2003; 8: 545-7.
3. Wang JW, Zhou LQ, Yang XZ, Ai JK, Xin DQ, et al. The NSBP1 expression is up-regulated in prostate cancer cell. Basic Med Sci Clin 2004; 24: 393-7.
4. King LM, Francomano CA. Characterization of a human gene encoding nucleosomal binding protein NSBP1. Genomics 2001; 71: 163-73.
5. Shirakawa H, Herrera JE, Bustin M, Postnikov Y. Targeting of high mobility group-14/-17 proteins in chromatin is independent of DNA sequence. J Biol Chem 2000; 275: 37937-44.
6. Bustin M, Neihart NK. Antibodies against chromosomal HMG proteins stain the cytoplasm of mammalian cells. Cell 1979; 16: 181-9.
7. Phair RD, Misteli T. High mobility of proteins in the mammalian cell nucleus. Nature 2000; 404: 604-9.
8. Bustin M. Chromatin unfolding and activation by HMGN chromosomal proteins. Trends Biochem Sci 2001; 26: 431-7. (Pubitemid 32607485)
9. Lim JH, West KL, Rubinstein Y, Bergel M, Postnikov Y V, et al. Chromosomal protein HMGN1 enhances the acetylation of lysine 14 in histone H3. EMBO J 2005; 24: 3038-48.
10. Trieschmann L, Postnikov YV, Rickers A, Bustin M. Modular structure of chromosomal proteins HMG-14 and HMG-17. Definition of a transcriptional enhancement domain distinct from the nucleosomal binding domain. Mol Cell Biol 1995; 15: 6663-9.
11. Catez F, Yang H, Tracey KJ, Reeves R, Misteli T, et al. Network of dynamic interactions between histone H1 and high-mobility-group proteins in chromatin. Mol Cell Biol 2004; 24: 4321-8.
12. Hock R, Furusawa T, Ueda T, Bustin M. HMG chromosomal proteins in development and disease. Trends Cell Biol 2007; 17: 72-9.
13. Korner U, Bustin M, Scheer U, Hock R. Developmental role of HMGN proteins in Xenopus laevis. Mech Dev 2003; 120: 1177-92.
14. Furusawa T, Lim JH, Catez F, Birger Y, Mackem S, et al. Down-regulation of nucleosomal binding protein HMGN1 expression during embryogenesis modulates Sox9 expression in chondrocytes. Mol Cell Biol 2006; 26: 592-604.
15. Lehtonen S, Lehtonen E. HMG-17 is an early marker of inductive interactions in the developing mouse kidney. Differentiation 2001; 67: 154-63.
16. Kuniyasu H, Chihara Y, Kondo H. Differential effects between amphoterin and advanced glycation end products on colon cancer cells. Int J Cancer 2003; 104: 722-7.
17. Cherukuri S, Hock R, Ueda T, Catez F, Rochman M, et al. Cell cycle-dependent binding of HMGN proteins to chromatin. Mol Biol Cell 2008; 19: 1816-24.
18. Birger Y, Catez F, Furusawa T, Lim JH, Prymakowska-Bosak M, et al. Increased tumorigenicity and sensitivity to ionizing radiation upon loss of chromosomal protein HMGN1. Cancer Res 2005; 65: 6711-8.
19. Rochman M, Postnikov Y, Correll S, Malicet C, Winco-vitch S, et al. The interaction of NSBP1/HMGN5 with nucleosomes in mediated chromatin compaction and modulates transcription. Mol Cell 2009; 35: 642-56.
20. Zhou LQ, Song G, He ZS, Li NC, Li M, et al. Effect of inhibiting nucleosomal binding protein 1 on proliferation of human prostate cancer cell line LNCaP. Chinese Medical Journal 2007; 86: 404-8.
21. Gao QZ, Lu JJ, Liu ZD, Zhang H, Wang SM, et al. Dexame thasone suppresses DU145 cell proliferation and cell cycle through inhibition of the extracellular signal-regulated kinase 1/2 pathway and cyclin D1 expression. Asian J Androl 2008; 10: 635-41.
22. Pines J, Hunter T. Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 1989; 58: 833-46.
23. Piaggio G, Farina A, Perrotti D, Manni I, Fuschi P, et al. Structure and growth-dependent regulation of the human cyclin B1 promoter. Exp Cell Res 1995; 216: 396-402.
24. Norbury C, Nurse P. Animal cell cycles and their control. Annu Rev Biochem 1992; 61: 441-70.
25. Carson DA, Ribeiro JM. Apoptosis and disease. Lancet 1993; 341: 1251-4.
26. Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev 1992; 11: 95-103.
27. Korsmeyer SJ. Regulators of cell death. Trends Genet 1995; 11: 101-5.
28. Williams GT, Smith CA. Molecular regulation of apoptosis: genetic controls on cell death. Cell 1993; 74: 777-9.
29. Zhang ZW, Yang ZM, Zheng YC, Chen ZD. Transgelin induces apoptosis of human prostate LNCaP cells through its interaction with p53. Asian J Androl 2010; 12: 186-95.
30. Bracey TS, Williams AC, Paraskeva C. Inhibition of radiation-induced G2 delay potentiates cell death by apop tosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function. Clin Cancer Res 1997; 3: 1371-81.
31. Aizawa K, Ueki K, Suzuki S, Yabusaki H, Kanda T, et al. Apoptosis and Bcl-2 expression in gastric carcinomas: corre-la tion with clinicopathological variables, p53 expression, cell proliferation and prognosis. Int J Oncol 1999; 14: 85-91.